Home > News > 177/Efficacy of biventricular stimulation after radiofrequency ablation of AV node in patients with persistent atrial fibrillation
Atrial Fibrillation
Read Time: < 1 min

177/Efficacy of biventricular stimulation after radiofrequency ablation of AV node in patients with persistent atrial fibrillation

Published Online: October 3rd 2008 European Journal of Arrhythmia & Electrophysiology. 2019;5(Suppl. 1):abstr177
Authors: BA Akhyt (Presenting Author) – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; RR Rekvava – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; KM Koshumbayeva – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; KN Madaliev – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; RT Kuanyshbekova – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan
Quick Links:
Article
Article Information
Article:

Objective: To evaluate the effectiveness of biventricular stimulation after the destruction of AV-node in patients with persistent atrial fibrillation (AF) and chronic heart failure (CHF).

Materials and methods: The observational single-centre study included 34 patients with mean age 61,8 ± 9.4 years. All the patients were diagnosed with CHF functional classes III, IV according to New York Heart Association (NYHA) and had poorly controlled persistent AF. At the enrolment point, patients received beta-blockers, ACE inhibitors, diuretics (including aldosterone antagonists), antiplatelet agents, anticoagulants, and statins (if indicated). Radiofrequency ablation of the AV node with implantation of a resynchronisation device (biventricular stimulation) were performed in all patients. Before and 12 months after the intervention we utilized an echocardiography to evaluate cardiac structure and its functions.

Results: The follow-up showed that 12 months after the intervention, there was an increase in the left ventricular ejection fraction (EF) from 32.95 ± 6.84% to 42.89 ± 8.91% (p<0.0001). We observed a decrease in the end-systolic volume (ESV) from 113.32 ± 48.54 ml to 93.83 38.3 ml (p<0.0001). There were no changes on the left ventricular stroke volume (73.41 ± 15.56 ml at the baseline compared with 74.26 ± 20.56 ml 12 months later, p<0.737). The six-minute walk test (SMWT) results increased from 241.3 ± 56.2 m to 362.1 ± 72.2 (p<0.0001).

Conclusions: Biventricular stimulation after radiofrequency ablation of AV node in patients with poorly controlled persistent atrial fibrillation, advanced CHF resulted with an EF, and SMWT improvement, as well as ESV decrease within 12 months observation period.

Article Information:

Further Resources

Share this Article
Related Content In Atrial Fibrillation
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72